Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 235 entries
Sorted by: Best Match Show Resources per page
Characteristics and Treatment Results of 5 Patients with Fibrous Dysplasia and Review of the Literature.

Case reports in endocrinology

Ozdemir Kutbay N, Sarer Yurekli B, Kartal Baykan E, Baydur Sahin S, Saygili F.
PMID: 26171261
Case Rep Endocrinol. 2015;2015:670809. doi: 10.1155/2015/670809. Epub 2015 Jun 14.

Aim. Fibrous dysplasia is a rare bone disease caused by missense mutation leading to abnormal fibroblast and osteoblast proliferation and increased bone resorption. FD can present in monostotic or polyostotic forms. About 3% of FD could be in association...

Cite
Ozdemir Kutbay N, Sarer Yurekli B, Kartal Baykan E, et al. Characteristics and Treatment Results of 5 Patients with Fibrous Dysplasia and Review of the Literature. Case Rep Endocrinol. 2015;2015:670809doi: 10.1155/2015/670809.
Ozdemir Kutbay, N., Sarer Yurekli, B., Kartal Baykan, E., Baydur Sahin, S., & Saygili, F. (2015). Characteristics and Treatment Results of 5 Patients with Fibrous Dysplasia and Review of the Literature. Case reports in endocrinology, 2015670809. https://doi.org/10.1155/2015/670809
Ozdemir Kutbay, Nilufer, et al. "Characteristics and Treatment Results of 5 Patients with Fibrous Dysplasia and Review of the Literature." Case reports in endocrinology vol. 2015 (2015): 670809. doi: https://doi.org/10.1155/2015/670809
Ozdemir Kutbay N, Sarer Yurekli B, Kartal Baykan E, Baydur Sahin S, Saygili F. Characteristics and Treatment Results of 5 Patients with Fibrous Dysplasia and Review of the Literature. Case Rep Endocrinol. 2015;2015:670809. doi: 10.1155/2015/670809. Epub 2015 Jun 14. PMID: 26171261; PMCID: PMC4480246.
Copy Download .nbib Format: NLM
Parathyroid carcinoma in pregnancy.

World journal of clinical cases

Baretić M, Tomić Brzac H, Dobrenić M, Jakovčević A.
PMID: 24868516
World J Clin Cases. 2014 May 16;2(5):151-6. doi: 10.12998/wjcc.v2.i5.151.

A 24-year-old female patient with parathyroid carcinoma, the rarest endocrine malignancy, had two pregnancies. In the first pregnancy, she had severe nausea and fatigue. Hypercalcemia and hyperparathyroidism were diagnosed in the postpartum period. Hyperemesis gravidarum masked a diagnosis of...

Cite
Baretić M, Tomić Brzac H, Dobrenić M, et al. Parathyroid carcinoma in pregnancy. World J Clin Cases. 2014;2(5):151-6doi: 10.12998/wjcc.v2.i5.151.
Baretić, M., Tomić Brzac, H., Dobrenić, M., & Jakovčević, A. (2014). Parathyroid carcinoma in pregnancy. World journal of clinical cases, 2(5), 151-6. https://doi.org/10.12998/wjcc.v2.i5.151
Baretić, Maja, et al. "Parathyroid carcinoma in pregnancy." World journal of clinical cases vol. 2,5 (2014): 151-6. doi: https://doi.org/10.12998/wjcc.v2.i5.151
Baretić M, Tomić Brzac H, Dobrenić M, Jakovčević A. Parathyroid carcinoma in pregnancy. World J Clin Cases. 2014 May 16;2(5):151-6. doi: 10.12998/wjcc.v2.i5.151. PMID: 24868516; PMCID: PMC4023310.
Copy Download .nbib Format: NLM
Quercus infectoria Gall Extract Enhanced the Proliferation and Activity of Human Fetal Osteoblast Cell Line (hFOB 1.19).

The Malaysian journal of medical sciences : MJMS

Hapidin H, Rozelan D, Abdullah H, Wan Hanaffi WN, Soelaiman IN.
PMID: 25892946
Malays J Med Sci. 2015 Jan-Feb;22(1):12-22.

BACKGROUND: The present study investigated the effects of Quercus infectoria (QI) gall extract on the proliferation, alkaline phosphatase (ALP), osteocalcin, and the morphology of a human fetal osteoblast cell line (hFOB 1.19).METHODS: The cells were cultured in Dulbecco's modified...

Cite
Hapidin H, Rozelan D, Abdullah H, et al. Quercus infectoria Gall Extract Enhanced the Proliferation and Activity of Human Fetal Osteoblast Cell Line (hFOB 1.19). Malays J Med Sci. 2015;22(1):12-22
Hapidin, H., Rozelan, D., Abdullah, H., Wan Hanaffi, W. N., & Soelaiman, I. N. (2015). Quercus infectoria Gall Extract Enhanced the Proliferation and Activity of Human Fetal Osteoblast Cell Line (hFOB 1.19). The Malaysian journal of medical sciences : MJMS, 22(1), 12-22.
Hapidin, Hermizi, et al. "Quercus infectoria Gall Extract Enhanced the Proliferation and Activity of Human Fetal Osteoblast Cell Line (hFOB 1.19)." The Malaysian journal of medical sciences : MJMS vol. 22,1 (2015): 12-22.
Hapidin H, Rozelan D, Abdullah H, Wan Hanaffi WN, Soelaiman IN. Quercus infectoria Gall Extract Enhanced the Proliferation and Activity of Human Fetal Osteoblast Cell Line (hFOB 1.19). Malays J Med Sci. 2015 Jan-Feb;22(1):12-22. PMID: 25892946; PMCID: PMC4390770.
Copy Download .nbib Format: NLM
Impact of Bisphosphonate on Orthodontic tooth movement and osteoclastic count: An Animal Study.

Journal of international oral health : JIOH

Venkataramana V, Chidambaram S, Reddy BV, Goud EV, Arafath M, Krishnan6 S.
PMID: 24876695
J Int Oral Health. 2014 Apr;6(2):1-8. Epub 2014 Apr 26.

Background : The aim of the current study is to examine the effect of systemically administered BP-Pamidronate, on Orthodontic Tooth Movement (OTM) along with osteoclastic quantification in New Zealand white rabbits. Materials & Methods : Twenty rabbits used in...

Cite
Venkataramana V, Chidambaram S, Reddy BV, et al. Impact of Bisphosphonate on Orthodontic tooth movement and osteoclastic count: An Animal Study. J Int Oral Health. 2014;6(2):1-8
Venkataramana, V., Chidambaram, S., Reddy, B. V., Goud, E. V., Arafath, M., & Krishnan6, S. (2014). Impact of Bisphosphonate on Orthodontic tooth movement and osteoclastic count: An Animal Study. Journal of international oral health : JIOH, 6(2), 1-8.
Venkataramana, V, et al. "Impact of Bisphosphonate on Orthodontic tooth movement and osteoclastic count: An Animal Study." Journal of international oral health : JIOH vol. 6,2 (2014): 1-8.
Venkataramana V, Chidambaram S, Reddy BV, Goud EV, Arafath M, Krishnan6 S. Impact of Bisphosphonate on Orthodontic tooth movement and osteoclastic count: An Animal Study. J Int Oral Health. 2014 Apr;6(2):1-8. Epub 2014 Apr 26. PMID: 24876695; PMCID: PMC4037805.
Copy Download .nbib Format: NLM
Caseous granuloma: tuberculosis or chronic recurrent multifocal osteomyelitis?.

Iranian journal of pediatrics

Assari R, Ziaee V, Ahmadinejad Z, Vasei M, Moradinejad MH.
PMID: 26019785
Iran J Pediatr. 2014 Dec;24(6):770-4. Epub 2014 Dec 05.

BACKGROUND: Chronic recurrent multifocal osteomyelitis (CREMO) is one of the autoinflammatory bone disorders due to disturbance in innate immune system. Up to now, there is no reported case of caseous granulomas in the CREMO. We report a boy with...

Cite
Assari R, Ziaee V, Ahmadinejad Z, et al. Caseous granuloma: tuberculosis or chronic recurrent multifocal osteomyelitis?. Iran J Pediatr. 2014;24(6):770-4
Assari, R., Ziaee, V., Ahmadinejad, Z., Vasei, M., & Moradinejad, M. H. (2014). Caseous granuloma: tuberculosis or chronic recurrent multifocal osteomyelitis?. Iranian journal of pediatrics, 24(6), 770-4.
Assari, Raheleh, et al. "Caseous granuloma: tuberculosis or chronic recurrent multifocal osteomyelitis?." Iranian journal of pediatrics vol. 24,6 (2014): 770-4.
Assari R, Ziaee V, Ahmadinejad Z, Vasei M, Moradinejad MH. Caseous granuloma: tuberculosis or chronic recurrent multifocal osteomyelitis?. Iran J Pediatr. 2014 Dec;24(6):770-4. Epub 2014 Dec 05. PMID: 26019785; PMCID: PMC4442841.
Copy Download .nbib Format: NLM
Effects of pamidronate administration on tooth eruption and mandibular growth in new born rats.

Journal of Istanbul University Faculty of Dentistry

Tuncer I, Delilbasi C, Deniz E, Soluk Tekkesin M, Olgac V, Sencift K.
PMID: 28955580
J Istanb Univ Fac Dent. 2017 Jan 02;51(1):8-14. doi: 10.17096/jiufd.16663. eCollection 2017.

PURPOSE: Bisphosphonates are commonly used drugs in pediatric patients in the treatment of osteoporotic diseases and various types of cancers. The purpose of this study was to evaluate the effects of pamidronate administration on mandibular growth and tooth eruption...

Cite
Tuncer I, Delilbasi C, Deniz E, et al. Effects of pamidronate administration on tooth eruption and mandibular growth in new born rats. J Istanb Univ Fac Dent. 2017;51(1):8-14doi: 10.17096/jiufd.16663.
Tuncer, I., Delilbasi, C., Deniz, E., Soluk Tekkesin, M., Olgac, V., & Sencift, K. (2017). Effects of pamidronate administration on tooth eruption and mandibular growth in new born rats. Journal of Istanbul University Faculty of Dentistry, 51(1), 8-14. https://doi.org/10.17096/jiufd.16663
Tuncer, Ibrahim, et al. "Effects of pamidronate administration on tooth eruption and mandibular growth in new born rats." Journal of Istanbul University Faculty of Dentistry vol. 51,1 (2017): 8-14. doi: https://doi.org/10.17096/jiufd.16663
Tuncer I, Delilbasi C, Deniz E, Soluk Tekkesin M, Olgac V, Sencift K. Effects of pamidronate administration on tooth eruption and mandibular growth in new born rats. J Istanb Univ Fac Dent. 2017 Jan 02;51(1):8-14. doi: 10.17096/jiufd.16663. eCollection 2017. PMID: 28955580; PMCID: PMC5573489.
Copy Download .nbib Format: NLM
Opsismodysplasia: Phosphate Wasting Osteodystrophy Responds to Bisphosphonate Therapy.

Frontiers in pediatrics

Khwaja A, Parnell SE, Ness K, Bompadre V, White KK.
PMID: 26157786
Front Pediatr. 2015 Jun 22;3:48. doi: 10.3389/fped.2015.00048. eCollection 2015.

UNLABELLED: We present two siblings affected with opsismodysplasia (OPS), a rare skeletal dysplasia caused by mutations in the inositol polyphosphate phosphatase-like 1 gene. The skeletal findings include short stature with postnatal onset micromelia, marked platyspondyly, squared metacarpals, delayed skeletal...

Cite
Khwaja A, Parnell SE, Ness K, et al. Opsismodysplasia: Phosphate Wasting Osteodystrophy Responds to Bisphosphonate Therapy. Front Pediatr. 2015;3:48doi: 10.3389/fped.2015.00048.
Khwaja, A., Parnell, S. E., Ness, K., Bompadre, V., & White, K. K. (2015). Opsismodysplasia: Phosphate Wasting Osteodystrophy Responds to Bisphosphonate Therapy. Frontiers in pediatrics, 348. https://doi.org/10.3389/fped.2015.00048
Khwaja, Ansab, et al. "Opsismodysplasia: Phosphate Wasting Osteodystrophy Responds to Bisphosphonate Therapy." Frontiers in pediatrics vol. 3 (2015): 48. doi: https://doi.org/10.3389/fped.2015.00048
Khwaja A, Parnell SE, Ness K, Bompadre V, White KK. Opsismodysplasia: Phosphate Wasting Osteodystrophy Responds to Bisphosphonate Therapy. Front Pediatr. 2015 Jun 22;3:48. doi: 10.3389/fped.2015.00048. eCollection 2015. PMID: 26157786; PMCID: PMC4476261.
Copy Download .nbib Format: NLM
The Effect of Locally Administered Pamidronate on Autogenous Bone Graft in Maxillofacial Reconstruction: A Randomized Clinical Trial.

International journal of organ transplantation medicine

Bayat M, Garajei A, Afshari Pour E, Hasheminasab M, Ghorbani Y, Kalantar Motamedi MH, Bahrami N.
PMID: 28299027
Int J Organ Transplant Med. 2017;8(1):43-47. Epub 2017 Feb 01.

BACKGROUND: Although bone grafts are commonly used in reconstructive surgeries, they are sensitive to local perfusion and are thus prone to severe resorption. Biphosphonates can inactivate osteoclasts and can be used to control the undesirable bone resorption.OBJECTIVE: To assess...

Cite
Bayat M, Garajei A, Afshari Pour E, et al. The Effect of Locally Administered Pamidronate on Autogenous Bone Graft in Maxillofacial Reconstruction: A Randomized Clinical Trial. Int J Organ Transplant Med. 2017;8(1):43-47
Bayat, M., Garajei, A., Afshari Pour, E., Hasheminasab, M., Ghorbani, Y., Kalantar Motamedi, M. H., & Bahrami, N. (2017). The Effect of Locally Administered Pamidronate on Autogenous Bone Graft in Maxillofacial Reconstruction: A Randomized Clinical Trial. International journal of organ transplantation medicine, 8(1), 43-47.
Bayat, M, et al. "The Effect of Locally Administered Pamidronate on Autogenous Bone Graft in Maxillofacial Reconstruction: A Randomized Clinical Trial." International journal of organ transplantation medicine vol. 8,1 (2017): 43-47.
Bayat M, Garajei A, Afshari Pour E, Hasheminasab M, Ghorbani Y, Kalantar Motamedi MH, Bahrami N. The Effect of Locally Administered Pamidronate on Autogenous Bone Graft in Maxillofacial Reconstruction: A Randomized Clinical Trial. Int J Organ Transplant Med. 2017;8(1):43-47. Epub 2017 Feb 01. PMID: 28299027; PMCID: PMC5347405.
Copy Download .nbib Format: NLM
Pharmacokinetics of Pamidronate Disodium in Cancer Patients after a Single Intravenous Infusion of 30-, 60- or 90-mg Dose over 4 or 24 Hours.

American journal of therapeutics

Cheung WK, Brunner L, Schoenfeld S, Knight R, Seaman J, Brox A, Batist G, John V, Chan K.
PMID: 11835092
Am J Ther. 1994 Oct;1(3):228-235. doi: 10.1097/00045391-199410000-00010.

The objective of this study was to determine the pharmacokinetics of pamidronate disodium in plasma and urine after a single intravenous infusion of the drug to cancer patients at risk for developing bone metastases. Thirty-six patients were randomized into...

Cite
Cheung WK, Brunner L, Schoenfeld S, et al. Pharmacokinetics of Pamidronate Disodium in Cancer Patients after a Single Intravenous Infusion of 30-, 60- or 90-mg Dose over 4 or 24 Hours. Am J Ther. 1994;1(3):228-235doi: 10.1097/00045391-199410000-00010.
Cheung, W. K., Brunner, L., Schoenfeld, S., Knight, R., Seaman, J., Brox, A., Batist, G., John, V., & Chan, K. (1994). Pharmacokinetics of Pamidronate Disodium in Cancer Patients after a Single Intravenous Infusion of 30-, 60- or 90-mg Dose over 4 or 24 Hours. American journal of therapeutics, 1(3), 228-235. https://doi.org/10.1097/00045391-199410000-00010
Cheung, W. K., et al. "Pharmacokinetics of Pamidronate Disodium in Cancer Patients after a Single Intravenous Infusion of 30-, 60- or 90-mg Dose over 4 or 24 Hours." American journal of therapeutics vol. 1,3 (1994): 228-235. doi: https://doi.org/10.1097/00045391-199410000-00010
Cheung WK, Brunner L, Schoenfeld S, Knight R, Seaman J, Brox A, Batist G, John V, Chan K. Pharmacokinetics of Pamidronate Disodium in Cancer Patients after a Single Intravenous Infusion of 30-, 60- or 90-mg Dose over 4 or 24 Hours. Am J Ther. 1994 Oct;1(3):228-235. doi: 10.1097/00045391-199410000-00010. PMID: 11835092.
Copy Download .nbib Format: NLM
Preliminary results of combined application of radioisotopes and biphosphonates in the management of pain associated with osteoblastic-osteolytic bone metastases of breast cancer.

Ortopedia, traumatologia, rehabilitacja

Baczyk M, Baczyk E, Sowiński J.
PMID: 18034012
Ortop Traumatol Rehabil. 2003 Apr 30;5(2):234-7.

Background. The aim of this study was to evaluate the effectivness of connected therapy using strontium 89 or Sm153 (osteoblastic component) and bisphosphonate therapy (osteolytic component) in the group of breast cancer patients with multiple osteoblastic-osteolytic (mixt) bone metastases....

Cite
Baczyk M, Baczyk E, Sowiński J. Preliminary results of combined application of radioisotopes and biphosphonates in the management of pain associated with osteoblastic-osteolytic bone metastases of breast cancer. Ortop Traumatol Rehabil. 2003;5(2):234-7
Baczyk, M., Baczyk, E., & Sowiński, J. (2003). Preliminary results of combined application of radioisotopes and biphosphonates in the management of pain associated with osteoblastic-osteolytic bone metastases of breast cancer. Ortopedia, traumatologia, rehabilitacja, 5(2), 234-7.
Baczyk, Maciej, et al. "Preliminary results of combined application of radioisotopes and biphosphonates in the management of pain associated with osteoblastic-osteolytic bone metastases of breast cancer." Ortopedia, traumatologia, rehabilitacja vol. 5,2 (2003): 234-7.
Baczyk M, Baczyk E, Sowiński J. Preliminary results of combined application of radioisotopes and biphosphonates in the management of pain associated with osteoblastic-osteolytic bone metastases of breast cancer. Ortop Traumatol Rehabil. 2003 Apr 30;5(2):234-7. PMID: 18034012.
Copy Download .nbib Format: NLM
Unusual Idiopathic Calcinosis Cutis Universalis in a Child.

Case reports in dermatology

Alabaz D, Mungan N, Turgut M, Dalay C.
PMID: 20652108
Case Rep Dermatol. 2009 Aug 28;1(1):16-22. doi: 10.1159/000227285.

Calcinosis cutis is an uncommon disorder characterized by the progressive deposition of crystals of calcium phosphate (hydroxyapatite) in the skin in various areas of the body. It is classified into four types according to etiology, namely as dystrophic if...

Cite
Alabaz D, Mungan N, Turgut M, et al. Unusual Idiopathic Calcinosis Cutis Universalis in a Child. Case Rep Dermatol. 2009;1(1):16-22doi: 10.1159/000227285.
Alabaz, D., Mungan, N., Turgut, M., & Dalay, C. (2009). Unusual Idiopathic Calcinosis Cutis Universalis in a Child. Case reports in dermatology, 1(1), 16-22. https://doi.org/10.1159/000227285
Alabaz, Derya, et al. "Unusual Idiopathic Calcinosis Cutis Universalis in a Child." Case reports in dermatology vol. 1,1 (2009): 16-22. doi: https://doi.org/10.1159/000227285
Alabaz D, Mungan N, Turgut M, Dalay C. Unusual Idiopathic Calcinosis Cutis Universalis in a Child. Case Rep Dermatol. 2009 Aug 28;1(1):16-22. doi: 10.1159/000227285. PMID: 20652108; PMCID: PMC2895204.
Copy Download .nbib Format: NLM
Long Term Cyclic Pamidronate Reduces Bone Growth by Inhibiting Osteoclast Mediated Cartilage-to-Bone Turnover in the Mouse.

The open orthopaedics journal

Evans KD, Sheppard LE, Grossman DI, Rao SH, Martin RB, Oberbauer AM.
PMID: 19572021
Open Orthop J. 2008 Jul 14;2:121-5. doi: 10.2174/1874325000802010121.

Bisphosphonates, used to treat diseases exhibiting increased osteoclast activity, reduce longitudinal bone growth through an as yet undefined mechanism. Pamidronate, an aminobisphosphonate, was given weekly to mice at 0, 1.25, or 2.50 mg/kg/wk beginning at 4 weeks of age....

Cite
Evans KD, Sheppard LE, Grossman DI, et al. Long Term Cyclic Pamidronate Reduces Bone Growth by Inhibiting Osteoclast Mediated Cartilage-to-Bone Turnover in the Mouse. Open Orthop J. 2008;2:121-5doi: 10.2174/1874325000802010121.
Evans, K. D., Sheppard, L. E., Grossman, D. I., Rao, S. H., Martin, R. B., & Oberbauer, A. M. (2008). Long Term Cyclic Pamidronate Reduces Bone Growth by Inhibiting Osteoclast Mediated Cartilage-to-Bone Turnover in the Mouse. The open orthopaedics journal, 2121-5. https://doi.org/10.2174/1874325000802010121
Evans, K D, et al. "Long Term Cyclic Pamidronate Reduces Bone Growth by Inhibiting Osteoclast Mediated Cartilage-to-Bone Turnover in the Mouse." The open orthopaedics journal vol. 2 (2008): 121-5. doi: https://doi.org/10.2174/1874325000802010121
Evans KD, Sheppard LE, Grossman DI, Rao SH, Martin RB, Oberbauer AM. Long Term Cyclic Pamidronate Reduces Bone Growth by Inhibiting Osteoclast Mediated Cartilage-to-Bone Turnover in the Mouse. Open Orthop J. 2008 Jul 14;2:121-5. doi: 10.2174/1874325000802010121. PMID: 19572021; PMCID: PMC2703200.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 235 entries